# Telix Manufacturing Solutions (TMS)

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/telix-manufacturing-solutions-tms
Canonical HTML page: https://getbiobrief.com/entity/telix-manufacturing-solutions-tms

## Recent coverage (1 stories)

### Telix H1: $68M R&D, ProstACT Global Advances Late-Stage Pipeline
2026-08-20 18:11:17 · Sentiment: Positive · Impact: 6/10 · Sources: 2

For biotech and pharma teams, Telix's update confirms a shift toward therapeutic radiopharmaceuticals. The company says it invested US$68 million in the therapeutics pipeline and advanced ProstACT Global, although the press release omits detailed trial data.
Full story: https://getbiobrief.com/story/telix-h1-2026-prostact-global-68m-rd

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.